A perfect storm: Converging paths of epilepsy and Alzheimer's dementia intersect in the hippocampal formation

Epilepsia

Volumn 52, Issue SUPPL. 1, 2011, Pages 39-46

  Noebels, Jeffrey ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

A ; APP; Hippocampal sprouting; Hyperexcitability; Nonconvulsive seizures

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; PRESENILIN 1; PRESENILIN 2;

ADULT; AGED; ALZHEIMER DISEASE; ANIMAL MODEL; ARTICLE; BRAIN ATROPHY; COMORBIDITY; CONTROLLED STUDY; DEMENTIA; ELECTROENCEPHALOGRAPHY; EPILEPSY; EPILEPTOGENESIS; GENE MUTATION; HIPPOCAMPUS; HUMAN; MOUSE; NERVE CELL EXCITABILITY; NERVE CELL NECROSIS; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SEIZURE; TEMPORAL LOBE EPILEPSY; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; BRAIN; DEMENTIA; DISEASE MODELS, ANIMAL; EPILEPSY; EPILEPSY, TEMPORAL LOBE; GENOTYPE; HIPPOCAMPUS; HUMANS; MICE; SEIZURES;

EID: 78651278360     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2010.02909.x     Document Type: Article

References (52)

1. Alberici A, Bonato C, Borroni B, Cotelli M, Mattioli F, Binetti G, Gennarelli M, Luca MD, Simonati A, Perani D, Rossini P, Padovani A,. (2007) Dementia, delusions and seizures: storage disease or genetic AD? Eur J Neurol 14: 1057-1059.
2. Amatniek JC, Hauser WA, DelCastillo-Castaneda C, Jacobs DM, Marder K, Bell K, Albert M, Brandt J, Stern Y,. (2006) Incidence and predictors of seizures in patients with Alzheimer's disease. Epilepsia 47: 867-872.
3. Bernhardt BC, Worsley KJ, Besson P, Concha L, Lerch JP, Evans AC, Bernasconi N,. (2008) Mapping limbic network organization in temporal lobe epilepsy using morphometric correlations: insights on the relation between mesiotemporal connectivity and cortical atrophy. Neuroimage 42: 515-524.
4. Cabrejo L, Guyant-Maréchal L, Laquerriáre A, Vercelletto M, De la Fourniáre F, Thomas-Antérion C, Verny C, Letournel F, Pasquier F, Vital A, Checler F, Frebourg T, Campion D, Hannequin D,. (2006) Phenotype associated with APP duplication in five families. Brain 129: 2966-2976.
5. Carne RP, Cook MJ, MacGregor LR, Kilpatrick CJ, Hicks RJ, O'Brien TJ,. (2007) Magnetic resonance imaging negative positron emission tomography positive temporal lobe epilepsy: FDG-PET pattern differs from mesial temporal lobe epilepsy. Mol Imaging Biol 9: 32-42.
6. Chauviáre L, Rafrafi N, Thinus-Blanc C, Bartolomei F, Esclapez M, Bernard C,. (2009) Early deficits in spatial memory and theta rhythm in experimental temporal lobe epilepsy. J Neurosci 29: 5402-5410.
7. Cirrito JR, Yamada KA, Finn MB, Sloviter RS, Bales KR, May PC, Schoepp DD, Paul SM, Mennerick S, Holtzman DM,. (2005) Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo. Neuron 48: 913-922.
8. Cirrito JR, Kang JE, Lee J, Stewart FR, Verges DK, Silverio LM, Bu G, Mennerick S, Holtzman DM,. (2008) Endocytosis is required for synaptic activity-dependent release of amyloid-beta in vivo. Neuron 58: 42-51.
9. Cloyd J, Hauser W, Towne A, Ramsay R, Mattson R, Gilliam F, Walczak T,. (2006) Epidemiological and medical aspects of epilepsy in the elderly. Epilepsy Res 68 (suppl 1): S39-S48.
10. de Lanerolle NC, Kim JH, Robbins RJ, Spencer DD,. (1989) Hippocampal interneuron loss and plasticity in human temporal lobe epilepsy. Brain Res 495: 387-395.
11. Del Vecchio R, Gold LH, Novick SJ, Wong G, Hyde LA,. (2004) Increased seizure threshold and severity in young transgenic CRND8 mice. Neurosci Lett 367: 164-167.
12. Edison P, Archer HA, Hinz R, Hammers A, Pavese N, Tai YF, Hotton G, Cutler D, Fox N, Kennedy A, Rossor M, Brooks DJ,. (2007) Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET study. Neurology 68: 501-508.
13. Fox NC, Kennedy AM, Harvey RJ, Lantos PL, Roques PK, Collinge J, Hardy J, Hutton M, Stevens JM, Warrington EK, Rossor MN,. (1997) Clinicopathological features of familial Alzheimer's disease associated with the M139V mutation in the Presenilin 1 gene. Pedigree but not mutation specific age at onset provides evidence for a further genetic factor. Brain 120: 491-501.
14. Gan L, Qiao S, Lan X, Chi L, Luo C, Lien L, Yan Liu Q, Liu R,. (2008) Neurogenic responses to amyloid-beta plaques in the brain of Alzheimer's disease-like transgenic (pPDGF-APPSw,Ind) mice. Neurobiol Dis 29: 71-80.
15. Helmstaedter C, Elger CE,. (2009) Chronic temporal lobe epilepsy: a neurodevelopmental or progressively dementing disease? Brain 132: 2822-2830.
16. Høgh P, Smith SJ, Scahill RI, Chan D, Harvey RJ, Fox NC, Rossor MN,. (2002) Epilepsy presenting as AD: neuroimaging, electroclinical features, and response to treatment. Neurology 58: 298-301.
17. Hu X, Zhou X, He W, Yang J, Xiong W, Wong P, Wilson CG, Yan R,. (2010) BACE1 deficiency causes altered neuronal activity and neurodegeneration. J Neurosci 30: 8819-8829.
18. Ito M, Echizenya N, Nemoto D, Kase M,. (2009) A case series of epilepsy-derived memory impairment resembling Alzheimer disease. Alzheimer Dis Assoc Disord 23: 406-409.
19. Jayadev S, Leverenz JB, Steinbart E, Stahl J, Klunk W, Yu CE, Bird TD,. (2010) Alzheimer's disease phenotypes and genotypes associated with mutations in presenilin 2. Brain 133: 1143-1154.
20. Jin K, Galvan V, Xie L, Mao XO, Gorostiza OF, Bredesen DE, Greenberg DA,. (2004a) Enhanced neurogenesis in Alzheimer's disease transgenic (PDGF-APPSw,Ind) mice. Proc Natl Acad Sci U S A 101: 13363-13367.
21. Jin K, Peel AL, Mao XO, Xie L, Cottrell BA, Henshall DC, Greenberg DA,. (2004b) Increased hippocampal neurogenesis in Alzheimer's disease. Proc Natl Acad Sci U S A 101: 343-347.
22. Kumar-Singh S, Dewachter I, Moechars D, Lübke U, De Jonghe C, Ceuterick C, Checler F, Naidu A, Cordell B, Cras P, Van Broeckhoven C, Van Leuven F,. (2000) Behavioral disturbances without amyloid deposits in mice overexpressing human amyloid precursor protein with Flemish (A692G) or Dutch (E693Q) mutation. Neurobiol Dis 7: 9-22.
23. LaFerla FM, Tinkle BT, Bieberich CJ, Haudenschild CC, Jay G,. (1995) The Alzheimer's A beta peptide induces neurodegeneration and apoptotic cell death in transgenic mice. Nat Genet 9: 21-30.
24. LaFerla FM, Green KN, Oddo S,. (2007) Intracellular amyloid-beta in Alzheimer's disease. Nat Rev Neurosci 8: 499-509.
25. Lalonde R, Dumont M, Staufenbiel M, Strazielle C,. (2005) Neurobehavioral characterization of APP23 transgenic mice with the SHIRPA primary screen. Behav Brain Res 157: 91-98.
26. Larner AJ,. (2010) Epileptic seizures in AD patients. Neuromolecular Med 12: 71-77.
27. Lauretani F, Maggio M, Nardelli A, Saccavini M, Ceda GP,. (2009) Is Non-Convulsive Status Epilepticus (NCSE) undertreated in patients affected by dementia? Aging Clin Exp Res 21: 363-364.
28. Lesné S, Ali C, Gabriel C, Croci N, MacKenzie ET, Glabe CG, Plotkine M, Marchand-Verrecchia C, Vivien D, Buisson A,. (2005) NMDA receptor activation inhibits alpha-secretase and promotes neuronal amyloid-beta production. J Neurosci 25: 9367-9377.
29. Lindquist SG, Nielsen JE, Stokholm J, Schwartz M, Batbayli M, Ballegaard M, Erdal J, Krabbe K, Waldemar G,. (2008) Atypical early-onset Alzheimer's disease caused by the Iranian APP mutation. J Neurol Sci 268: 124-130.
30. Lopez-Toledano MA, Shelanski M,. (2004) Neurogenic effect of β-amyloid peptide in the development of neural stem cells. J Neurosci 24: 5439-5444.
31. Marcon G, Giaccone G, Cupidi C, Balestrieri M, Beltrami CA, Finato N, Bergonzi P, Sorbi S, Bugiani O, Tagliavini F,. (2004) Neuropathological and clinical phenotype of an Italian Alzheimer family with M239V mutation of presenilin 2 gene. J Neuropathol Exp Neurol 63: 199-209.
32. Menendez M,. (2005) Down syndrome, Alzheimer's disease and seizures. Brain Dev 27: 246-252.
33. Minkeviciene R, Rheims S, Dobszay MB, Zilberter M, Hartikainen J, Fülöp L, Penke B, Zilberter Y, Harkany T, Pitkänen A, Tanila H,. (2009) Amyloid beta-induced neuronal hyperexcitability triggers progressive epilepsy. J Neurosci 29: 3453-3462.
34. Moechars D, Lorent K, De Strooper B, Dewachter I, Van Leuven F,. (1996) Expression in brain of amyloid precursor protein mutated in the a-secretase site causes disturbed behavior, neuronal degeneration and premature death in transgenic mice. EMBO J 15: 1265-1274.
35. Nilsson D, Fohlen M, Jalin C, Dorfmuller G, Bulteau C, Delalande O,. (2009) Foramen ovale electrodes in the preoperative evaluation of temporal lobe epilepsy in children. Epilepsia 50: 2085-2096.
36. Palop JJ, Mucke L,. (2009) Epilepsy and cognitive impairments in Alzheimer disease. Arch Neurol 66: 435-440.
37. Palop JJ, Chin J, Roberson ED, Wang J, Thwin MT, Bien-Ly N, Yoo J, Ho KO, Yu GQ, Kreitzer A, Finkbeiner S, Noebels JL, Mucke L,. (2007) Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease. Neuron 55: 697-711.
38. Parent JM, Murphy GG,. (2008) Mechanisms and functional significance of aberrant seizure-induced hippocampal neurogenesis. Epilepsia 49 (suppl 5): 19-25.
39. Rao SC, Dove G, Cascino GD, Petersen RC,. (2009) Recurrent seizures in patients with dementia: frequency, seizure types, and treatment outcome. Epilepsy Behav 14: 118-120.
40. Rossor MN, Newman S, Frackowiak RS, Lantos P, Kennedy AM,. (1993) Alzheimer's disease families with amyloid precursor protein mutations. Ann N Y Acad Sci 695: 198-202.
41. Scarameas N, Honig LS, Choi H, Cantero J, Brandt J, Blacker D, Albert M, Amatniek JC, Marder K, Bell K, Hauser WA, Stern Y,. (2009) Seizures in Alzheimer disease: who, when, and how common? Arch Neurol 66: 992-997.
42. Scharfman HE,. (2007) The CA3 "backprojection" to the dentate gyrus. Prog Brain Res 163: 627-637.
43. Shigeto H, Morioka T, Hisada K, Nishio S, Ishibashi H, Kira D, Tobimatsu S, Kato M,. (2002) Feasibility and limitations of magnetoencephalographic detection of epileptic discharges: simultaneous recording of magnetic fields and electrocorticography. Neurol Res 24: 531-536.
44. Shrimpton AE, Schelper RL, Linke RP, Hardy J, Crook R, Dickson DW, Ishizawa T, Davis RL,. (2007) A presenilin 1 mutation (L420R) in a family with early onset Alzheimer disease, seizures and cotton wool plaques, but not spastic paraparesis. Neuropathology 27: 228-232.
45. Steinbach JP, Müller U, Leist M, Li ZW, Nicotera P, Aguzzi A,. (1998) Hypersensitivity to seizures in beta-amyloid precursor protein deficient mice. Cell Death Differ 5: 858-866.
46. Sun B, Halabisky B, Zhou Y, Palop JJ, Yu G, Mucke L, Gan L,. (2009) Imbalance between GABAergic and glutamatergic transmission impairs adult neurogenesis in an animal model of Alzheimer's disease. Cell Stem Cell 5: 624-633.
47. Sutula TP, Dudek FE,. (2007) Unmasking recurrent excitation generated by mossy fiber sprouting in the epileptic dentate gyrus: an emergent property of a complex system. Prog Brain Res 163: 541-563.
48. Takao M, Ghetti B, Murrell JR, Unverzagt FW, Giaccone G, Tagliavini F, Bugiani O, Piccardo P, Hulette CM, Crain BJ, Farlow MR, Heyman A,. (2001) Ectopic white matter neurons, a developmental abnormality that may be caused by the PSEN1 S169L mutation in a case of familial AD with myoclonus and seizures. J Neuropathol Exp Neurol 60: 1137-1152.
49. Tatum WO IV, Ross J, Cole AJ,. (1998) Epileptic pseudodementia. Neurology 50: 1472-1475.
50. Thompson PM, Hayashi KM, de Zubicaray G, Janke AL, Rose SE, Semple J, Herman D, Hong MS, Dittmer SS, Doddrell DM, Toga AW,. (2003) Dynamics of gray matter loss in Alzheimer's disease. J Neurosci 23: 994-1005.
51. Tombini M, Koch G, Placidi F, Sancesario G, Marciani MG, Bernardi G,. (2005) Temporal lobe epileptic activity mimicking dementia: a case report. Eur J Neurol 12: 805-806.
52. Velez-Pardo C, Arellano JI, Cardona-Gomez P, Jimenez Del Rio M, Lopera F, De Felipe J,. (2004) CA1 hippocampal neuronal loss in familial Alzheimer's disease presenilin-1 E280A mutation is related to epilepsy. Epilepsia 45: 751-756.